Showing results (11-20 of 21) with videos related to
Sort By:
Pageof 3
Blood Cancer Discovery|November 15, 2021
NOT-Gated CD93 CAR T Cells Effectively Target AML with Minimized Endothelial Cross-ReactivityRebecca M Richards, Feifei Zhao, Katherine A Freitas, et al.Cell|March 20, 2021
Discovery and functional interrogation of SARS-CoV-2 RNA-host protein interactionsRyan A Flynn, Julia A Belk, Yanyan Qi, et al.Cell|September 22, 2020
Single-Cell Analyses Identify Brain Mural Cells Expressing CD19 as Potential Off-Tumor Targets for CAR-T ImmunotherapiesKevin R Parker, Denis Migliorini, Eric Perkey, et al.Cancer Discovery|March 17, 2021
Surface Proteomics Reveals CD72 as a Target for <i>In Vitro</i>-Evolved Nanobody-Based CAR-T Cells in <i>KMT2A/MLL1</i>-Rearranged B-ALLMatthew A Nix, Kamal Mandal, Huimin Geng, et al.Cell|October 5, 2023
Mitigation of chromosome loss in clinical CRISPR-Cas9-engineered T cellsConnor A Tsuchida, Nadav Brandes, Raymund Bueno, et al.Biorxiv : the Preprint Server for Biology|March 30, 2023
Mitigation of chromosome loss in clinical CRISPR-Cas9-engineered T cellsConnor A Tsuchida, Nadav Brandes, Raymund Bueno, et al.Cell|April 28, 2022
Enhanced safety and efficacy of protease-regulated CAR-T cell receptorsLouai Labanieh, Robbie G Majzner, Dorota Klysz, et al.Science (New York, N.Y.)|April 2, 2021
Transient rest restores functionality in exhausted CAR-T cells through epigenetic remodelingEvan W Weber, Kevin R Parker, Elena Sotillo, et al.Nature Medicine|April 25, 2018
Transcript-indexed ATAC-seq for precision immune profilingAnsuman T Satpathy, Naresha Saligrama, Jason D Buenrostro, et al.Cancer Cell|December 31, 2021
GPC2-CAR T cells tuned for low antigen density mediate potent activity against neuroblastoma without toxicitySabine Heitzeneder, Kristopher R Bosse, Zhongyu Zhu, et al.Pageof 3